On October 30, 2021, ALAN signed a collaboration agreement with Scientific Education Support (SES). The aim of the collaboration agreement is to achieve improved disease awareness and education through initiatives utilizing our patient leadership in acute leukemias and SES’ expertise in communications and medical education. Check out the press release for further information.
ALAN is collaborating with SES on Know ALL to ensure that the acute lymphoblastic leukemia (ALL) community has access to the latest information and resources, providing the best possible support and care for patients with ALL and their families. Know ALL is a global education and awareness initiative that provides patients and carers with the information, resources, and support they need to deal with ALL.
Know ALL is guided by a highly experienced global ambassador group who meet regularly to ensure the voice of patients and their families is at the core of the initiative.
The mission of Know ALL is to drive awareness of ALL globally through community collaborations, while continuing to raise awareness of the resources and support currently available. Know ALL aspires to facilitate and improve ALL knowledge worldwide and develop community-based initiatives to overcome current and future challenges.
In addition, Zack Pemberton-Whiteley (ALAN’s Chair) joined the Know AML ambassador group. Similar to Know ALL, Know AML is also guided by a highly experienced global ambassador group who meet regularly to steer and guide the initiative, founded in 2017. The ambassador group consists of patients and carers, patient advocates, healthcare professionals, and industry representatives.